{"id":335,"date":"2015-01-06T09:56:17","date_gmt":"2015-01-06T09:56:17","guid":{"rendered":"https:\/\/delveinsightblog.wordpress.com\/?p=335"},"modified":"2025-05-05T18:18:51","modified_gmt":"2025-05-05T12:48:51","slug":"are-you-ready-to-embrace-gene-therapy-delveinsights-gene-therapy-reports","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/are-you-ready-to-embrace-gene-therapy-delveinsights-gene-therapy-reports","title":{"rendered":"Are you ready to embrace Gene Therapy?"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_76 counter-hierarchy ez-toc-counter ez-toc-white ez-toc-container-direction\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<label for=\"ez-toc-cssicon-toggle-item-69fae4b51f69a\" class=\"ez-toc-cssicon-toggle-label\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/label><input type=\"checkbox\"  id=\"ez-toc-cssicon-toggle-item-69fae4b51f69a\"  aria-label=\"Toggle\" \/><nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.delveinsight.com\/blog\/are-you-ready-to-embrace-gene-therapy-delveinsights-gene-therapy-reports\/#Gene_Therapy_The_%E2%80%9CBig_Value%E2%80%9D_Market\" >Gene Therapy: The \u201cBig Value\u201d Market!<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.delveinsight.com\/blog\/are-you-ready-to-embrace-gene-therapy-delveinsights-gene-therapy-reports\/#About_Gene_Therapy\" >About Gene Therapy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.delveinsight.com\/blog\/are-you-ready-to-embrace-gene-therapy-delveinsights-gene-therapy-reports\/#Gene_Therapy_Reports_Understanding_the_potential_of_Gene_Therapy_Market\" >Gene Therapy Reports: Understanding the potential of Gene Therapy Market<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/www.delveinsight.com\/blog\/are-you-ready-to-embrace-gene-therapy-delveinsights-gene-therapy-reports\/#DelveInsights_Gene_Therapy_Reports\" >DelveInsight\u2019s Gene Therapy Reports<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/www.delveinsight.com\/blog\/are-you-ready-to-embrace-gene-therapy-delveinsights-gene-therapy-reports\/#DelveInsights_Gene_Therapy_Reports_Reasons_to_buy\" >DelveInsight\u2019s Gene Therapy Reports: Reasons to buy<\/a><\/li><\/ul><\/nav><\/div>\n<blockquote>\n<h3 style=\"text-align: center;\"><span class=\"ez-toc-section\" id=\"Gene_Therapy_The_%E2%80%9CBig_Value%E2%80%9D_Market\"><\/span><span style=\"color: #a83d3d;\">Gene Therapy: The \u201cBig Value\u201d Market!<\/span><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<\/blockquote>\n<p style=\"text-align: justify;\"><span style=\"color: #29abab;\">Gene therapy has been under scientific research for over 2 decades, but viable therapies have yet to gain commercial acceptance due to safety and delivery-related issues. However, Pfizer\u2019s move and some other recent developments in the industry suggest that the therapy may be coming off age. With the superlatively well-funded biotech Moderna Therapeutics raising another $450 million in venture cash, for its mRNA based proprietary approach to treat previously undruggable targets in a wide range of disease areas (with 45 preclinical programs in its pipeline), it has become clear that the Gene therapy market is going to be of great interest for many companies globally due to the possibility of a permanent cure that it offers for any of the more than 10,000 human diseases caused by a defect in a single gene.<\/span><\/p>\n<h3><span class=\"ez-toc-section\" id=\"About_Gene_Therapy\"><\/span><span style=\"color: #4980b3;\">About Gene Therapy<\/span><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify;\"><span style=\"color: #ad8224;\">Gene therapy aims to fix a genetic problem at its source. By adding a corrected copy of a defective gene, gene therapy promises to help diseased tissues and organs work properly. This approach is different from traditional drug-based approaches, which may treat symptoms but not the underlying genetic problems. Put simply, it introduces a &#8220;good&#8221; gene into a person who has a disease caused by a &#8220;faulty&#8221; gene.<\/span><\/p>\n<h3><span class=\"ez-toc-section\" id=\"Gene_Therapy_Reports_Understanding_the_potential_of_Gene_Therapy_Market\"><\/span><span style=\"color: #4980b3;\">Gene Therapy Reports: Understanding the potential of Gene Therapy Market<\/span><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify;\"><span style=\"color: #ad8224;\">During the past two decades gene therapy has made important medical advances. Within this short time span, it has moved from the conceptual stage to technology development and laboratory research to clinical translational trials for a variety of deadly diseases. The researchers have learned from their mistakes and developed much more realistic approach and solutions to many of the problems which led to major clinical and commercial successes. It has become an upcoming research area in 21<sup>st<\/sup> century with the industry\u2019s collective pipeline brimming with therapies close to 300.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #ad8224;\">There is a significant increase in the companies coming up with gene therapies for various therapeutic areas such as Novartis, GlaxoSmithKline, Sanofi, UniQure Biopharma, Oxford BioMedica etc., which are operating in the gene therapy domain. Moreover recent academic and industry partnerships for example between Celgene Corporation and Baylor College of Medicine, GSK and the Roswell Park Cancer Institute etc., are driving new gene therapy research.<\/span><\/p>\n<h3 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"DelveInsights_Gene_Therapy_Reports\"><\/span><span style=\"color: #4980b3;\">DelveInsight\u2019s Gene Therapy Reports<\/span><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify;\"><span style=\"color: #ad8224;\"><strong><em>DelveInsight\u2019s<\/em> Gene Therapy Reports<\/strong> cover the entire gene therapy market insights including technology assessments, licensing opportunities, collaborations, market trends, pipeline coverage and competitive landscape. The report essentially provides DelveInsight\u2019s proprietary market and pipeline analytics which identifies the front runners of all therapeutic areas. It also identifies the potential market movers and future regulatory landscape. These reports provide complete insight over all the therapy areas associated with gene therapy like; <em><span style=\"color: #ff0000;\">Oncology, Genitourinary, Dermatology, Central nervous system, Genetic Disorders, Hematological disorders, Metabolic disorders, Ophthalmology, Cardiovascular disease, Respiratory , Immunology<\/span>, <\/em>and many more&#8230;<\/span><\/p>\n<h3><span class=\"ez-toc-section\" id=\"DelveInsights_Gene_Therapy_Reports_Reasons_to_buy\"><\/span><span style=\"color: #4980b3;\">DelveInsight\u2019s Gene Therapy Reports: Reasons to buy<\/span><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<ul>\n<li style=\"text-align: justify;\"><span style=\"color: #ad8224;\">Complete Market and Pipeline intelligence and complete understanding over therapeutics development for gene therapy.<\/span><\/li>\n<li style=\"text-align: justify;\"><span style=\"color: #ad8224;\">Devise corrective measures for pipeline projects by understanding gene therapies for specific therapy areas.<\/span><\/li>\n<li style=\"text-align: justify;\"><span style=\"color: #ad8224;\">Developing strategic initiatives to support your gene therapy development activities.<\/span><\/li>\n<li style=\"text-align: justify;\"><span style=\"color: #ad8224;\">Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.<\/span><\/li>\n<li style=\"text-align: justify;\"><span style=\"color: #ad8224;\">Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope<\/span><\/li>\n<li style=\"text-align: justify;\"><span style=\"color: #ad8224;\">Evaluate the marketing and pipeline strategy for gene therapies and their Funding availabilities.<\/span><\/li>\n<li style=\"text-align: justify;\"><span style=\"color: #ad8224;\">Identifying the upcoming leaders in the gene therapy market in the coming years.<\/span><\/li>\n<li style=\"text-align: justify;\"><span style=\"color: #ad8224;\">Getting a first mover advantage by identifying the early market winners for clinical and preclinical gene therapies.<\/span><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><span style=\"color: #4980b3;\"><strong>For more info on Gene Therapy Reports for various Therapeutic areas refer to the following links:<\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #0000ff;\"><strong><a style=\"color: #0000ff;\" href=\"https:\/\/delveinsightblog.wordpress.com\/2014\/12\/19\/delveinsights-oncology-based-gene-therapy-reports\/\">DelveInsight\u2019s Oncology based Gene Therapy\u00a0Reports<\/a><\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #0000ff;\"><strong><a style=\"color: #0000ff;\" href=\"https:\/\/delveinsightblog.wordpress.com\/2014\/12\/19\/delveinsights-otolaryngology-based-gene-therapy-reports\/\">DelveInsight\u2019s Otolaryngology based Gene Therapy\u00a0Reports<\/a><\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #0000ff;\"><strong><a style=\"color: #0000ff;\" href=\"https:\/\/delveinsightblog.wordpress.com\/2014\/12\/20\/delveinsights-central-nervous-system-based-gene-therapy-reports\/\">DelveInsight\u2019s Central Nervous System based Gene Therapy\u00a0Reports<\/a><\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #0000ff;\"><strong><a style=\"color: #0000ff;\" href=\"https:\/\/delveinsightblog.wordpress.com\/2014\/12\/20\/delveinsights-genitourinary-sex-hormones-based-gene-therapy-reports\/\">DelveInsight\u2019s Genitourinary &amp; Sex hormones based Gene Therapy\u00a0Reports<\/a><\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #0000ff;\"><strong><a style=\"color: #0000ff;\" href=\"https:\/\/delveinsightblog.wordpress.com\/2014\/12\/22\/delveinsights-dermatology-based-gene-therapy-reports\/\">DelveInsight\u2019s Dermatology based Gene Therapy\u00a0Reports<\/a><\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #0000ff;\"><strong><a style=\"color: #0000ff;\" href=\"https:\/\/delveinsightblog.wordpress.com\/2014\/12\/22\/delveinsights-genetic-disorders-based-gene-therapy-reports\/\">DelveInsight\u2019s Genetic disorders based Gene Therapy\u00a0Reports<\/a><\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #0000ff;\"><strong><a style=\"color: #0000ff;\" href=\"https:\/\/delveinsightblog.wordpress.com\/2014\/12\/23\/delveinsights-gastrointestinal-based-gene-therapy-reports\/\">DelveInsight\u2019s Gastrointestinal based Gene Therapy\u00a0Reports<\/a><\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #0000ff;\"><strong><a style=\"color: #0000ff;\" href=\"https:\/\/delveinsightblog.wordpress.com\/2014\/12\/23\/delveinsights-infectious-disorders-based-gene-therapy-reports\/\">DelveInsight\u2019s Infectious disorders based Gene Therapy\u00a0Reports<\/a><\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #0000ff;\"><strong><a style=\"color: #0000ff;\" href=\"https:\/\/delveinsightblog.wordpress.com\/2014\/12\/24\/delveinsights-metabolic-disorders-based-gene-therapy-reports\/\">DelveInsight\u2019s Metabolic disorders based Gene Therapy\u00a0Reports<\/a><\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #0000ff;\"><strong><a style=\"color: #0000ff;\" href=\"https:\/\/delveinsightblog.wordpress.com\/2014\/12\/24\/delveinsights-musculoskeletal-disorders-based-gene-therapy-reports\/\">DelveInsight\u2019s Musculoskeletal disorders based Gene Therapy\u00a0Reports<\/a><\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #0000ff;\"><strong><a style=\"color: #0000ff;\" href=\"https:\/\/delveinsightblog.wordpress.com\/2014\/12\/29\/delveinsights-cardiovascular-disorders-based-gene-therapy-reports\/\">DelveInsight\u2019s Cardiovascular disorders based Gene Therapy\u00a0Reports<\/a><\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #0000ff;\"><strong><a style=\"color: #0000ff;\" href=\"https:\/\/delveinsightblog.wordpress.com\/2014\/12\/29\/delveinsights-immunology-based-gene-therapy-reports\/\">DelveInsight\u2019s Immunology based Gene Therapy\u00a0Reports<\/a><\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #0000ff;\"><strong><a style=\"color: #0000ff;\" href=\"https:\/\/delveinsightblog.wordpress.com\/2014\/12\/30\/delveinsights-respiratory-disorders-based-gene-therapy-reports\/\">DelveInsight\u2019s Respiratory disorders based Gene Therapy\u00a0Reports<\/a><\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #0000ff;\"><strong><a style=\"color: #0000ff;\" href=\"https:\/\/delveinsightblog.wordpress.com\/2014\/12\/30\/delveinsights-hematological-disorders-based-gene-therapy-reports\/\">DelveInsight\u2019s Hematological disorders based Gene Therapy\u00a0Reports<\/a><\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #0000ff;\"><strong><a style=\"color: #0000ff;\" href=\"https:\/\/delveinsightblog.wordpress.com\/2014\/12\/30\/delveinsights-ophthalmologic-disorders-based-gene-therapy-reports\/\">DelveInsight\u2019s Ophthalmologic disorders based Gene Therapy\u00a0Reports<\/a><\/strong><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Gene Therapy: The \u201cBig Value\u201d Market! Gene therapy has been under scientific research for over 2 decades, but viable therapies have yet to gain commercial acceptance due to safety and delivery-related issues. However, Pfizer\u2019s move and some other recent developments in the industry suggest that the therapy may be coming off age. With the superlatively [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[17],"tags":[144,158,173,180,210,252,258,260,263,265,282,314,329,356,378,386,397,411,427,432,443,479,482,515,558],"industry":[17225],"therapeutic_areas":[17235],"class_list":["post-335","post","type-post","status-publish","format-standard","hentry","category-articles","tag-cardiovascular-disorders","tag-central-nervous-system","tag-collaborations","tag-competitive-landscape","tag-dermatology","tag-gastrointestinal","tag-gene-therapy","tag-gene-therapy-reports","tag-genetic-disorders","tag-genitourinary-sex-hormones","tag-hematological-disorders","tag-immunology","tag-infectious-disorders","tag-licensing-opportunities","tag-market-insight","tag-market-trends","tag-metabolic-disorders","tag-musculoskeletal-disorders","tag-oncology","tag-ophthalmologic-disorders","tag-otolaryngology","tag-pipeline-coverage","tag-pipeline-intelligence","tag-respiratory-disorders","tag-technology-assessments","industry-pharmaceutical","therapeutic_areas-cell-and-gene-therapy"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.8 (Yoast SEO v25.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Global Trends of Gene Therapy Market | Delveinsight<\/title>\n<meta name=\"description\" content=\"Gene therapy has been under scientific research for over 2 decades, but viable therapies have yet to gain commercial acceptance due to safety and deliver..\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/are-you-ready-to-embrace-gene-therapy-delveinsights-gene-therapy-reports\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Trends of Gene Therapy Market | Delveinsight\" \/>\n<meta property=\"og:description\" content=\"Gene therapy has been under scientific research for over 2 decades, but viable therapies have yet to gain commercial acceptance due to safety and deliver..\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/are-you-ready-to-embrace-gene-therapy-delveinsights-gene-therapy-reports\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2015-01-06T09:56:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-05T12:48:51+00:00\" \/>\n<meta name=\"author\" content=\"DelveInsight\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DelveInsight\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Global Trends of Gene Therapy Market | Delveinsight","description":"Gene therapy has been under scientific research for over 2 decades, but viable therapies have yet to gain commercial acceptance due to safety and deliver..","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/are-you-ready-to-embrace-gene-therapy-delveinsights-gene-therapy-reports","og_locale":"en_US","og_type":"article","og_title":"Global Trends of Gene Therapy Market | Delveinsight","og_description":"Gene therapy has been under scientific research for over 2 decades, but viable therapies have yet to gain commercial acceptance due to safety and deliver..","og_url":"https:\/\/www.delveinsight.com\/blog\/are-you-ready-to-embrace-gene-therapy-delveinsights-gene-therapy-reports","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2015-01-06T09:56:17+00:00","article_modified_time":"2025-05-05T12:48:51+00:00","author":"DelveInsight","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"DelveInsight","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.delveinsight.com\/blog\/are-you-ready-to-embrace-gene-therapy-delveinsights-gene-therapy-reports","url":"https:\/\/www.delveinsight.com\/blog\/are-you-ready-to-embrace-gene-therapy-delveinsights-gene-therapy-reports","name":"Global Trends of Gene Therapy Market | Delveinsight","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"datePublished":"2015-01-06T09:56:17+00:00","dateModified":"2025-05-05T12:48:51+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a"},"description":"Gene therapy has been under scientific research for over 2 decades, but viable therapies have yet to gain commercial acceptance due to safety and deliver..","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/are-you-ready-to-embrace-gene-therapy-delveinsights-gene-therapy-reports"]}]},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a","name":"DelveInsight","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","caption":"DelveInsight"}}]}},"author_meta":{"display_name":"DelveInsight","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/gtadmin"},"featured_img":null,"coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Articles<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Articles<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Cardiovascular disorders<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Central nervous system<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">collaborations<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Competitive landscape<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Dermatology<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Gastrointestinal<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Gene therapy<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Gene Therapy Reports<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Genetic Disorders<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Genitourinary &amp; Sex hormones<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Hematological disorders<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Immunology<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Infectious disorders<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">licensing opportunities<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Market Insight<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">market trends<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Metabolic disorders<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Musculoskeletal disorders<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Oncology<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Ophthalmologic disorders<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Otolaryngology<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Pipeline coverage<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Pipeline intelligence<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Respiratory disorders<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">technology assessments<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Cardiovascular disorders<\/span>","<span class=\"advgb-post-tax-term\">Central nervous system<\/span>","<span class=\"advgb-post-tax-term\">collaborations<\/span>","<span class=\"advgb-post-tax-term\">Competitive landscape<\/span>","<span class=\"advgb-post-tax-term\">Dermatology<\/span>","<span class=\"advgb-post-tax-term\">Gastrointestinal<\/span>","<span class=\"advgb-post-tax-term\">Gene therapy<\/span>","<span class=\"advgb-post-tax-term\">Gene Therapy Reports<\/span>","<span class=\"advgb-post-tax-term\">Genetic Disorders<\/span>","<span class=\"advgb-post-tax-term\">Genitourinary &amp; Sex hormones<\/span>","<span class=\"advgb-post-tax-term\">Hematological disorders<\/span>","<span class=\"advgb-post-tax-term\">Immunology<\/span>","<span class=\"advgb-post-tax-term\">Infectious disorders<\/span>","<span class=\"advgb-post-tax-term\">licensing opportunities<\/span>","<span class=\"advgb-post-tax-term\">Market Insight<\/span>","<span class=\"advgb-post-tax-term\">market trends<\/span>","<span class=\"advgb-post-tax-term\">Metabolic disorders<\/span>","<span class=\"advgb-post-tax-term\">Musculoskeletal disorders<\/span>","<span class=\"advgb-post-tax-term\">Oncology<\/span>","<span class=\"advgb-post-tax-term\">Ophthalmologic disorders<\/span>","<span class=\"advgb-post-tax-term\">Otolaryngology<\/span>","<span class=\"advgb-post-tax-term\">Pipeline coverage<\/span>","<span class=\"advgb-post-tax-term\">Pipeline intelligence<\/span>","<span class=\"advgb-post-tax-term\">Respiratory disorders<\/span>","<span class=\"advgb-post-tax-term\">technology assessments<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 11 years ago","modified":"Updated 1 year ago"},"absolute_dates":{"created":"Posted on Jan 6, 2015","modified":"Updated on May 5, 2025"},"absolute_dates_time":{"created":"Posted on Jan 6, 2015 9:56 am","modified":"Updated on May 5, 2025 6:18 pm"},"featured_img_caption":"","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/335","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=335"}],"version-history":[{"count":1,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/335\/revisions"}],"predecessor-version":[{"id":31688,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/335\/revisions\/31688"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=335"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=335"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=335"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=335"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=335"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}